
RxSight, Inc.: updates and filings
Price
$5.01
November 18, 2026Market cap $207M
What Ploutos Investor adds for RxSight
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 3, 2026next Feb 4, 2027
A rough estimate from when it has reported before, which has varied. The company announces the date itself.
November 2026
August 2026
July 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 10, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 3, 2026Shares registered for employeesFormS-8
- Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 3, 2026Results of operationsForm8-K
- Nov 2, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 8, 2026Filing (amendment)FormSC TO-I/A
- Aug 25, 2026Filing (amendment)FormSC TO-I/A
- Aug 19, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 10, 2026FilingFormSC TO-I
- Aug 5, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 5, 2026Results of operationsForm8-K
- Aug 4, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 23, 2026Shares registered for employeesFormS-8
- Jul 17, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 15, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jul 6, 2026Material agreement entered, Regulation FD disclosureForm8-K
- Jul 6, 2026Results of operationsForm8-K
- Jun 16, 2026Shareholder voteForm8-K
- May 29, 2026Conflict minerals reportFormSD
- May 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 6, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 10, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 3, 2026 | S-8 | Shares registered for employees | Document |
| Nov 3, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 3, 2026 | 8-K | Results of operations | Document |
| Nov 2, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 8, 2026 | SC TO-I/A | Filing (amendment) | Document |
| Aug 25, 2026 | SC TO-I/A | Filing (amendment) | Document |
| Aug 19, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 10, 2026 | SC TO-I | Filing | Document |
| Aug 5, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 5, 2026 | 8-K | Results of operations | Document |
| Aug 4, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 23, 2026 | S-8 | Shares registered for employees | Document |
| Jul 17, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 15, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jul 6, 2026 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Jul 6, 2026 | 8-K | Results of operations | Document |
| Jun 16, 2026 | 8-K | Shareholder vote | Document |
| May 29, 2026 | SD | Conflict minerals report | Document |
| May 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 6, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jul 30, 2002.
The full analysis
What do RxSight's filings show?
The filings are where every one of RxSight's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.